Plasmodium falciparum clearance in clinical studies of artesunate-amodiaquine and comparator treatments in sub-Saharan Africa, 1999–2009

BACKGROUND: Artemisinin-based combination therapy (ACT) is the recommended first-line therapy for uncomplicated Plasmodium falciparum malaria worldwide but decreased artemisinin susceptibility, phenotypically characterized as slow parasite clearance time (PCT), has now been reported in Southeast Asi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zwang, Julien, Dorsey, Grant, Mårtensson, Andreas, d’Alessandro, Umberto, Ndiaye, Jean-Louis, Karema, Corine, Djimde, Abdoulaye, Brasseur, Philippe, Sirima, Sodiomon B, Olliaro, Piero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987158/
https://www.ncbi.nlm.nih.gov/pubmed/24666562
http://dx.doi.org/10.1186/1475-2875-13-114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987158/
https://www.ncbi.nlm.nih.gov/pubmed/24666562
http://dx.doi.org/10.1186/1475-2875-13-114

Ejemplares similares